(Q40630136)

22 September 2017

Recombinant toxin DAB389EGF is cytotoxic to human pancreatic cancer cells (English)

1 reference

22 September 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1173

16 March 2024

3

Arthur E Frankel

1 reference

22 September 2017

Girish Mishra

1

1 reference

22 September 2017

Tie Fu Liu

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

22 September 2017

http://www.tandfonline.com/doi/pdf/10.1517/14712598.3.7.1173

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1173

Expert Opinion on Biological Therapy

16 March 2024

published in

1 reference

22 September 2017

3

1 reference

22 September 2017

7

1 reference

22 September 2017

1173-1180

1 reference

22 September 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Survival in 1001 patients with carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Surgical palliation for pancreatic cancer. The UCLA experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Histologic and biologic patterns of microscopic pancreatic ductal adenocarcinomas detected incidentally at autopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Developments in the systemic therapy of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

New drugs for patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

The type 1 (EGFR-related) family of growth factor receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Molecular characterization of key diphtheria toxin:receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Penetration of protein toxins into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Fusion protein toxins based on diphtheria toxin: selective targeting of growth factor receptors of eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

DAB389EGF fusion protein therapy of refractory glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Pancreatic cancer: preliminary experience with sodium iodide fluorodeoxyglucose positron emission tomography in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

The role of ultrasound in biliary and pancreatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Diagnosis, staging, and surveillance of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

An Orthotopic Nude Mouse Model for Evaluating Pathophysiology and Therapy of Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Mouse models of metastatic pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Peptide toxins directed at the matrix dissolution systems of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1173

Adjuvant therapy for pancreatic cancer

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1173

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

16 March 2024

11

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1173

16 March 2024

27

63

1834

LIU TF

2003

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1173

CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas

16 March 2024

30

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1173

Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine

16 March 2024

40

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1173

16 March 2024

41

35

2269

REDDY JK

1975

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1173

16 March 2024

Identifiers

1 reference

22 September 2017

1 reference